Teleflex Incorporated (NYSE:TFX) Breaks 52 Week High Record

Teleflex Incorporated (NYSE:TFX)

March 15th, 2019

With markets going up Teleflex Incorporated closed the day up $4.04 Friday, a 1.35% increase, closing at $302.90. Furthermore it hit a new 52 week high of $302.95. In addition to finishing higher, trading volumes were solid at 243.00% of normal which can indicate investors see opportunities.

Expectations from 11 analysts indicates that Teleflex Incorporated might grow somewhat (1.71%), while Finbox has calculated (with low uncertainty) a fair value price of $255.88.

Market Sectors

The market sectors were mixed Friday with a majority of the sectors trending up. Information Technology saw the biggest increase of the day (1.22%), while Real Estate saw the biggest drop (-0.38%). Information Technology has seen the biggest year-to-date gain at 16.35%.

Real Estate and Industrials saw turn arounds from their five day positive performance, Real Estate with a drop of -0.38%.

Sector Breakdown

  • Information Technology went up with a 1.22% change.
  • Consumer Discretionary went up with a 0.71% change.
  • Financials went up with a 0.64% change.
  • Consumer Staples went up with a 0.50% change.
  • Healthcare went up with a 0.49% change.
  • Utilities went up with a 0.47% change.
  • Materials went up with a 0.20% change.
  • Communication Services went up with a 0.01% change.
  • Energy went down with a -0.08% change.
  • Industrials went down with a -0.25% change.
  • Real Estate went down with a -0.38% change.

Teleflex Incorporated Info

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

All amounts in USD unless otherwise indicated

TFX daily update
TFX daily update

Via UnSplash

Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.

Tell us what you think